Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 6Terminated 4Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Neoplasms 18Recurrence 16Pancreatic Neoplasms 16Multiple Myeloma 15Prostatic Neoplasms 13Advanced Solid Tumors 12Carcinoma, Hepatocellular 11Stomach Neoplasms 10Leukemia, Myeloid, Acute 10Advanced Solid Tumor 10Ovarian Neoplasms 9Triple Negative Breast Neoplasms 8Small Cell Lung Carcinoma 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Uterine Cervical Neoplasms 4Lymphoma 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Advanced Cancer × Clear all
NCT07605962 2026-05-26

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

United Immunity, co., Ltd.

Phase 1/2 Not yet recruiting
140 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡